
    
      This single center trial will be single-blind to the subject, controlled, fully randomized
      with crossover design in 22 healthy females aged 18-40 years old.

      Subjects will attend 8 visits. At screening (V0), 3 consecutive feeding days (V1-V3), 14 days
      after last stable isotope intake again 3 consecutive feeding days (V4-V6), and 14 days after
      last stable isotope intake blood sampling (V7).
    
  